LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

COMMON STOCK | |

Last Closing

CAD 20.94

Change

+0.19 (+0.92)%

Market Cap

CAD 0.01B

Volume

4.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

+0.10 (+0.41%)

CAD 192.15B
TD-PFD:CA Toronto Dominion Bank Pref D

+0.01 (+0.04%)

CAD 161.10B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.27 (+1.07%)

CAD 153.48B
TD-PFL:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 141.08B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

+0.01 (+0.04%)

CAD 140.97B
ENB-PFA:CA Enbridge Inc Pref 9

+0.20 (+1.09%)

CAD 111.44B
ENB-PFV:CA Enbridge Inc Pref 5

+0.16 (+0.74%)

CAD 109.77B
ENB-PFC:CA Enbridge Inc Pref 11

+0.23 (+1.31%)

CAD 105.51B
ENB-PFG:CA Enbridge Inc Pref 15

+0.13 (+0.76%)

CAD 100.73B
ENB-PFU:CA Enbridge Inc Pref L

+0.16 (+0.78%)

CAD 80.58B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.72% N/A N/A 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.72% N/A N/A 33% F
Trailing 12 Months  
Capital Gain -6.35% N/A N/A 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.35% N/A N/A 21% F
Trailing 5 Years  
Capital Gain 11.68% N/A N/A 51% F
Dividend Return 6.88% N/A N/A 33% F
Total Return 18.56% N/A N/A 49% F
Average Annual (5 Year Horizon)  
Capital Gain 1.74% N/A N/A 50% F
Dividend Return 2.90% N/A N/A 49% F
Total Return 1.17% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 7.40% N/A N/A 78% C+
Risk Adjusted Return 39.23% N/A N/A 65% D
Market Capitalization 0.01B N/A N/A 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike